Total Payments
$235,267
2024 Payments
$13,266
Companies
20
Transactions
319
Medicare Patients
59
Medicare Billing
$5,013
Payment Breakdown by Category
Other$180,818 (76.9%)
Travel$33,503 (14.2%)
Consulting$10,390 (4.4%)
Food & Beverage$9,713 (4.1%)
Research$743.81 (0.3%)
Education$99.02 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $180,618 | 88 | 76.8% |
| Travel and Lodging | $33,503 | 96 | 14.2% |
| Consulting Fee | $10,390 | 4 | 4.4% |
| Food and Beverage | $9,713 | 126 | 4.1% |
| Unspecified | $743.81 | 3 | 0.3% |
| Honoraria | $200.00 | 1 | 0.1% |
| Education | $99.02 | 1 | 0.0% |
Payments by Type
General
$234,523
316 transactions
Research
$743.81
3 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $230,228 | 266 | $0 (2024) |
| Cook Medical LLC | $991.24 | 16 | $0 (2024) |
| Eli Lilly and Company | $743.81 | 3 | $0 (2020) |
| ABBVIE INC. | $668.20 | 7 | $0 (2024) |
| PFIZER INC. | $406.15 | 4 | $0 (2019) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $362.84 | 3 | $0 (2019) |
| Covidien LP | $359.62 | 3 | $0 (2018) |
| Intercept Pharmaceuticals, Inc. | $298.96 | 2 | $0 (2019) |
| Ambu A/S | $200.00 | 1 | $0 (2021) |
| Eisai Inc. | $177.70 | 2 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $13,266 | 21 | Gilead Sciences, Inc. ($13,082) |
| 2023 | $11,090 | 19 | Gilead Sciences, Inc. ($10,884) |
| 2022 | $11,919 | 21 | Gilead Sciences, Inc. ($11,817) |
| 2021 | $9,640 | 15 | Gilead Sciences, Inc. ($9,313) |
| 2020 | $8,973 | 18 | Gilead Sciences, Inc. ($8,720) |
| 2019 | $55,281 | 68 | Gilead Sciences, Inc. ($53,351) |
| 2018 | $51,970 | 78 | Gilead Sciences, Inc. ($50,811) |
| 2017 | $73,127 | 79 | Gilead Sciences Inc ($72,249) |
All Payment Transactions
319 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | Gilead Sciences, Inc. | Epclusa (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,830.00 | General |
| Category: HCV | ||||||
| 11/13/2024 | Gilead Sciences, Inc. | Epclusa (Drug) | Food and Beverage | In-kind items and services | $120.60 | General |
| Category: HCV | ||||||
| 11/13/2024 | Gilead Sciences, Inc. | Epclusa (Drug) | Travel and Lodging | In-kind items and services | $17.99 | General |
| Category: HCV | ||||||
| 08/08/2024 | Gilead Sciences, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $600.00 | General |
| 07/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $27.52 | General |
| Category: IMMUNOLOGY | ||||||
| 07/01/2024 | Cook Medical LLC | INSTINCT (Device) | Food and Beverage | Cash or cash equivalent | $4.86 | General |
| Category: Endoscopy | ||||||
| 06/24/2024 | Cook Medical LLC | INSTINCT (Device) | Food and Beverage | Cash or cash equivalent | $85.65 | General |
| Category: Endoscopy | ||||||
| 06/03/2024 | Cook Medical LLC | INSTINCT (Device) | Food and Beverage | Cash or cash equivalent | $65.88 | General |
| Category: Endoscopy | ||||||
| 04/12/2024 | Gilead Sciences, Inc. | Epclusa (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,830.00 | General |
| Category: HCV | ||||||
| 04/10/2024 | Gilead Sciences, Inc. | Epclusa (Drug) | Food and Beverage | In-kind items and services | $108.93 | General |
| Category: HCV | ||||||
| 04/10/2024 | Gilead Sciences, Inc. | Epclusa (Drug) | Travel and Lodging | In-kind items and services | $41.01 | General |
| Category: HCV | ||||||
| 04/05/2024 | Gilead Sciences, Inc. | — | Travel and Lodging | In-kind items and services | $85.10 | General |
| 04/05/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.57 | General |
| 03/02/2024 | Gilead Sciences, Inc. | — | Travel and Lodging | In-kind items and services | $501.71 | General |
| 03/02/2024 | Gilead Sciences, Inc. | — | Travel and Lodging | In-kind items and services | $397.59 | General |
| 03/02/2024 | Gilead Sciences, Inc. | — | Travel and Lodging | In-kind items and services | $298.50 | General |
| 03/02/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $123.27 | General |
| 03/02/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $49.99 | General |
| 03/02/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $49.99 | General |
| 02/08/2024 | Gilead Sciences, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,240.00 | General |
| 01/25/2024 | Gilead Sciences, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,770.00 | General |
| 09/22/2023 | Gilead Sciences, Inc. | Epclusa (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,830.00 | General |
| Category: HCV | ||||||
| 09/20/2023 | Gilead Sciences, Inc. | Epclusa (Drug) | Food and Beverage | In-kind items and services | $106.33 | General |
| Category: HCV | ||||||
| 09/20/2023 | Gilead Sciences, Inc. | Epclusa (Drug) | Travel and Lodging | In-kind items and services | $59.68 | General |
| Category: HCV | ||||||
| 09/14/2023 | Cook Medical LLC | HEMOSPRAY (Device) | Food and Beverage | Cash or cash equivalent | $95.73 | General |
| Category: Endoscopy | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL, PLACEBO-CONTROLLED INDUCTION STUDY OF MIRIKIZUMAB IN CONVENTIONAL-FAILED AND BIOLOGIC-FAILED PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS (LUCENT 1) | Eli Lilly and Company | $715.57 | 2 |
| A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL-ARM, PLACEBO-CONTROLLED MAINTENANCE STUDY OF MIRIKIZUMAB IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS (LUCENT 2) | Eli Lilly and Company | $28.24 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 59 | 63 | $15,286 | $5,013 |
Total Patients
59
Total Services
63
Medicare Billing
$5,013
Procedure Codes
3
All Medicare Procedures & Services
3 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 32 | 36 | $8,908 | $2,901 | 32.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $3,850 | $1,245 | 32.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 16 | 16 | $2,528 | $866.50 | 34.3% |
About Dr. Bashar Attar, MD
Dr. Bashar Attar, MD is a Gastroenterology healthcare provider based in Chicago, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1790795664.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bashar Attar, MD has received a total of $235,267 in payments from pharmaceutical and medical device companies, with $13,266 received in 2024. These payments were reported across 319 transactions from 20 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($180,618).
As a Medicare-enrolled provider, Attar has provided services to 59 Medicare beneficiaries, totaling 63 services with total Medicare billing of $5,013. Data is available for 1 year (2023–2023), covering 3 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Other Specialties Internal Medicine, Hepatology
- Location Chicago, IL
- Active Since 08/09/2006
- Last Updated 04/21/2021
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1790795664
Products in Payments
- Epclusa (Drug) $133,344
- Vosevi (Drug) $4,216
- XELJANZ (Drug) $320.15
- Mavyret (Drug) $316.20
- HEMOSPRAY (Device) $307.31
- Vemlidy (Drug) $224.78
- PillCam (Device) $193.60
- Cook Medical Hemostasis (Device) $183.94
- Lenvima (Drug) $177.70
- INSTINCT (Device) $156.39
- OCA (Drug) $149.66
- OCALIVA (Drug) $149.30
- COOK MEDICAL HEMOSTASIS (Device) $148.27
- RELISTOR (Drug) $124.98
- UCERIS (Drug) $124.98
- Trulance (Drug) $124.81
- ZENPEP (Drug) $124.75
- XIFAXAN (Drug) $112.88
- PHASIX (Device) $104.93
- Hemospray (Device) $100.20
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Chicago
Stephen Hanauer, Md, MD
Gastroenterology — Payments: $1.6M
Gastroenterology $1.6M
David Rubin
Gastroenterology — Payments: $1.6M
Gastroenterology $1.6M
Dr. Darren Brenner, M.d, M.D
Gastroenterology — Payments: $1.4M
Gastroenterology $1.4M
Steven Flamm, Md, MD
Gastroenterology — Payments: $1.3M
Gastroenterology $1.3M
Russell Cohen
Gastroenterology — Payments: $834,887
Gastroenterology $834,887
Atman Shah
Gastroenterology — Payments: $766,122
Gastroenterology $766,122